250
Views
15
CrossRef citations to date
0
Altmetric
Original

Over-expression of Decoy Receptor 3 in Gastric Precancerous Lesions and Carcinoma

&
Pages 297-304 | Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yu Zhang, Jie Luo, Rongquan He, Wenting Huang, Zuyun Li, Ping Li, Yiwu Dang, Gang Chen & Shikang Li. (2016) Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases. OncoTargets and Therapy 9, pages 4959-4968.
Read now
Minhua Rong, Rongquan He, Yiwu Dang & Gang Chen. (2014) Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues. Upsala Journal of Medical Sciences 119:1, pages 19-24.
Read now
Meisongzhu Yang, Gang Chen, Yiwu Dang & Dianzhong Luo. (2010) Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients. Upsala Journal of Medical Sciences 115:4, pages 232-237.
Read now

Articles from other publishers (12)

Cheng‐Yu Yang, Chih‐Kung Lin, Cheng‐Chih Hsieh, Chang‐Huei Tsao, Chun‐Shu Lin, Bo Peng, Yen‐Tzu Chen, Chun‐Chieh Ting, Wei‐Chin Chang, Gu‐Jiun Lin, Huey‐Kang Sytwu & Yuan‐Wu Chen. (2018) Anti‐oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient‐derived tumor xenograft model. Head & Neck 41:5, pages 1260-1269.
Crossref
Jiang Chen, Xiao-Zhong Guo, Hong-Yu Li, Jia-Jun Zhao & Wen-Da Xu. (2017) Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer in vitro . World Journal of Gastroenterology 23:5, pages 817.
Crossref
Linjiang Pan, Suning Huang, Rongquan He, Minhua Rong, Yiwu Dang & Gang Chen. (2014) Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues. European Journal of Medical Research 19:1.
Crossref
Yi-Qiang Jiang, Teng-Fei Zhong, Yi-Wu Dang, Ling-Song Zou, Liu Yang, Xia Yang & Gang Chen. (2014) Overexpression and Clinicopathological Contribution of DcR3 in Bladder Urothelial Carcinoma Tissues. Asian Pacific Journal of Cancer Prevention 15:21, pages 9137-9142.
Crossref
Qiuwan Wu, Yahong Zheng, Donghan Chen, Xiaohong Li, Chuanhui Lu & Zhiming Zhang. (2014) Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis. Journal of Surgical Research 188:2, pages 459-465.
Crossref
Suning Huang, Gang Chen, Yiwu Dang & Long-Hua Chen. (2014) Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma. The Scientific World Journal 2014, pages 1-7.
Crossref
Suning Huang, Rongquan He, Minhua Rong, Yiwu Dang & Gang Chen. (2014) Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells. BioMed Research International 2014, pages 1-15.
Crossref
MITSUNORI TODA, TERUYA KAWAMOTO, TAKESHI UEHA, KENTA KISHIMOTO, HITOMI HARA, NAOMASA FUKASE, YASUO ONISHI, RISA HARADA, MASAYA MINODA, MASAHIRO KUROSAKA & TOSHIHIRO AKISUE. (2013) ‘Decoy’ and ‘non-decoy’ functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells. International Journal of Oncology 43:3, pages 703-712.
Crossref
Marcos W. Steinberg, Timothy C. Cheung & Carl F. Ware. (2011) The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunological Reviews 244:1, pages 169-187.
Crossref
ZHICHENG GE, ANDREW J. SANDERS, LIN YE & WEN G. JIANG. (2011) Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer. Experimental and Therapeutic Medicine 2:2, pages 167-172.
Crossref
Gang Chen, Minhua Rong & Dianzhong Luo. (2010) TNFRSF6B neutralization antibody inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell. Pathology - Research and Practice 206:9, pages 631-641.
Crossref
Tomohiro Morishige, Yasuo Yoshioka, Hiroshi Inakura, Aya Tanabe, Xinglei Yao, Shin-ichi Tsunoda, Yasuo Tsutsumi, Yohei Mukai, Naoki Okada & Shinsaku Nakagawa. (2010) Creation of a LIGHT mutant with the capacity to evade the decoy receptor for cancer therapy. Biomaterials 31:12, pages 3357-3363.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.